Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 8,100 shares at $15.10 ($122K) on 2008-01-09, disclosed to the SEC on 2008-01-10.
Scheduled sale ($122k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.86 | 100 | $1K | 1.2% |
| 2 | $14.87 | 200 | $3K | 2.4% |
| 3 | $14.91 | 300 | $4K | 3.7% |
| 4 | $14.93 | 200 | $3K | 2.4% |
| 5 | $14.98 | 300 | $4K | 3.7% |
| 6 | $15.00 | 700 |
| $11K |
| 8.6% |
| 7 | $15.02 | 500 | $8K | 6.1% |
| 8 | $15.03 | 500 | $8K | 6.1% |
| 9 | $15.04 | 300 | $5K | 3.7% |
| 10 | $15.05 | 500 | $8K | 6.1% |
| 11 | $15.06 | 200 | $3K | 2.5% |
| 12 | $15.07 | 400 | $6K | 4.9% |
| 13 | $15.08 | 200 | $3K | 2.5% |
| 14 | $15.09 | 100 | $2K | 1.2% |
| 15 | $15.10 | 200 | $3K | 2.5% |
| 16 | $15.11 | 400 | $6K | 4.9% |
| 17 | $15.12 | 300 | $5K | 3.7% |
| 18 | $15.14 | 300 | $5K | 3.7% |
| 19 | $15.15 | 300 | $5K | 3.7% |
| 20 | $15.16 | 100 | $2K | 1.2% |
| 21 | $15.19 | 100 | $2K | 1.2% |
| 22 | $15.23 | 500 | $8K | 6.2% |
| 23 | $15.27 | 200 | $3K | 2.5% |
| 24 | $15.28 | 100 | $2K | 1.2% |
| 25 | $15.35 | 300 | $5K | 3.8% |
| 26 | $15.39 | 200 | $3K | 2.5% |
| 27 | $15.43 | 200 | $3K | 2.5% |
| 28 | $15.48 | 100 | $2K | 1.3% |
| 29 | $15.50 | 200 | $3K | 2.5% |
| 30 | $15.59 | 100 | $2K | 1.3% |
| Total | $15.12 avg | 8,100 | $122K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $42K | — | Filing → |